UK approves new Covid disease treatment
Britain becomes the first country to authorize Merck and Ridgeback Biotherapeutics' antiviral molnupiravir to treat mild-to-moderate Covid-19
It is the world’s first oral antiviral to be authorized anywhere for the treatment of Covid-19. The drug comes in capsule form and will be known as Lagevrio.
The companies have sought US Food and Drug Administration emergency use authorization
for the drug, and the FDA said it will convene its Antimicrobial Drugs Advisory Committee on November 30 to discuss molnupiravir’s ability to treat mild-to-moderate Covid-19 in adults who are at high risk for severe disease, including hospitalization or death.
Merck and Ridgeback also say the European Medicines Agency has initiated a rolling review of its marketing application.
© Copyright LaPresse